Literature DB >> 8058132

Dystonia after head trauma.

M S Lee1, J O Rinne, A Ceballos-Baumann, P D Thompson, C D Marsden.   

Abstract

Dystonia is a rare consequence of head trauma. We describe 10 such cases and review 19 similar patients reported in the literature. Twenty-two of the 29 patients suffered head injury during the first or second decade of life. There was a variable delay between the head trauma and the onset of dystonia. In 18 cases with severe head injury, this interval (median, 18 months; range, 1 month to 9 years) was longer than in 11 cases with mild head injury (median, 14 days; range, 3 days to 5 years). In our series, nine of the 10 cases started as a focal dystonia and one as a hemidystonia. The dystonia progressed and spread over several months or years. Two cases remained as focal dystonias, but the others developed segmental, hemi-, multifocal, or generalized dystonia. On brain imaging studies (CT or MRI), the most frequent lesion site was in the contralateral basal ganglia or thalamus, but two cases had normal brain scans. Dysfunction of the lenticulothalamic neuronal circuit seems to be related to the development of dystonia following head trauma.

Entities:  

Mesh:

Year:  1994        PMID: 8058132     DOI: 10.1212/wnl.44.8.1374

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  12 in total

1.  Focal dystonia after chemotherapy: a case series.

Authors:  A Brashear; E Siemers
Journal:  J Neurooncol       Date:  1997-09       Impact factor: 4.130

Review 2.  The natural history and treatment of acquired hemidystonia: report of 33 cases and review of the literature.

Authors:  C Chuang; S Fahn; S J Frucht
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-01       Impact factor: 10.154

3.  Decreased [18F]spiperone binding in putamen in idiopathic focal dystonia.

Authors:  J S Perlmutter; M K Stambuk; J Markham; K J Black; L McGee-Minnich; J Jankovic; S M Moerlein
Journal:  J Neurosci       Date:  1997-01-15       Impact factor: 6.167

4.  Possible risk factors for primary adult onset dystonia: a case-control investigation by the Italian Movement Disorders Study Group.

Authors:  G Defazio; A Berardelli; G Abbruzzese; V Lepore; V Coviello; D Acquistapace; L Capus; F Carella; M T De Berardinis; G Galardi; P Girlanda; S Maurri; A Albanese; L Bertolasi; R Liguori; A Rossi; L Santoro; G Tognoni; P Livrea
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-01       Impact factor: 10.154

5.  Risk factors for spread of primary adult onset blepharospasm: a multicentre investigation of the Italian movement disorders study group.

Authors:  G Defazio; A Berardelli; G Abbruzzese; V Coviello; F Carella; M T De Berardinis; G Galardi; P Girlanda; S Maurri; M Mucchiut; A Albanese; M Basciani; L Bertolasi; R Liguori; N Tambasco; L Santoro; G Assennato; P Livrea
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-11       Impact factor: 10.154

6.  Traumatic basal ganglia hematoma following closed head injuries in children.

Authors:  Ahmet Öğrenci; Murat Şakir Ekşi; Barış Gün; Orkun Koban
Journal:  Childs Nerv Syst       Date:  2016-03-18       Impact factor: 1.475

7.  Possible Post-Traumatic Focal Dystonia Associated with Tau Pathology Localized to Putamen-Globus Pallidus.

Authors:  Diego Iacono; Patricia Lee; Mark Hallett; Daniel Perl
Journal:  Mov Disord Clin Pract       Date:  2018-08-08

8.  Hemidystonia as an initial manifestation of leptomeningeal metastasis.

Authors:  Hyun-Jung Jung; Seong-Min Choi; Byeong-Chae Kim
Journal:  J Mov Disord       Date:  2009-10-30

Review 9.  Neuroinflammation as a Common Feature of Neurodegenerative Disorders.

Authors:  Leonardo Guzman-Martinez; Ricardo B Maccioni; Víctor Andrade; Leonardo Patricio Navarrete; María Gabriela Pastor; Nicolas Ramos-Escobar
Journal:  Front Pharmacol       Date:  2019-09-12       Impact factor: 5.810

10.  3D texture analysis reveals imperceptible MRI textural alterations in the thalamus and putamen in progressive myoclonic epilepsy type 1, EPM1.

Authors:  Sanna Suoranta; Kirsi Holli-Helenius; Päivi Koskenkorva; Eini Niskanen; Mervi Könönen; Marja Äikiä; Hannu Eskola; Reetta Kälviäinen; Ritva Vanninen
Journal:  PLoS One       Date:  2013-07-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.